1. Home
  2. EVI vs ELTX Comparison

EVI vs ELTX Comparison

Compare EVI & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EVI Industries Inc.

EVI

EVI Industries Inc.

HOLD

Current Price

$15.42

Market Cap

204.6M

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$3.53

Market Cap

185.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVI
ELTX
Founded
1959
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
204.6M
185.4M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
EVI
ELTX
Price
$15.42
$3.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$35.00
$18.00
AVG Volume (30 Days)
83.9K
4.2M
Earning Date
05-15-2026
05-12-2026
Dividend Yield
1.81%
N/A
EPS Growth
32.43
39.29
EPS
0.31
N/A
Revenue
$389,830,000.00
$2,301,000.00
Revenue This Year
$15.53
N/A
Revenue Next Year
$3.83
N/A
P/E Ratio
$49.55
N/A
Revenue Growth
10.26
N/A
52 Week Low
$14.06
$2.66
52 Week High
$34.82
$16.00

Technical Indicators

Market Signals
Indicator
EVI
ELTX
Relative Strength Index (RSI) 42.43 37.15
Support Level $14.06 $2.66
Resistance Level $21.36 $9.30
Average True Range (ATR) 0.92 0.57
MACD 0.13 0.02
Stochastic Oscillator 40.12 29.89

Price Performance

Historical Comparison
EVI
ELTX

About EVI EVI Industries Inc.

EVI Industries Inc is a value-added distributor and service provider in the commercial laundry industry. It sells and leases commercial laundry equipment, specializing in washing, drying, finishing, material handling, water heating, power generation, and water reuse applications. The company supports its equipment offerings with installation, maintenance, and repair services through a large network of trained technicians. It serves a wide range of customers, including commercial, industrial, institutional, government, and retail sectors. Geographically, the company serves various countries including United States, Canada, the Caribbean, and Latin America.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Share on Social Networks: